Page 32 - Glucose Monitoring Devices

References 27

[77] Young L, Buse J, Weaver M, Vu M, Mitchell C, Blakeney T, et al. Glucose self-
monitoring in noneinsulin-treated patients with type 2 diabetes in primary care
settings. JAMA Internal Medicine 2017;177:920. https://doi.org/10.1001/
jamainternmed.2017.1233.
[78] Parkin C, Buskirk A, Hinnen D, Axel-Schweitzer M. Results that matter: structured vs.
unstructured self-monitoring of blood glucose in type 2 diabetes. Diabetes Research
and Clinical Practice 2012;97:6e15. https://doi.org/10.1016/j.diabres.2012.03.002.
[79] Polonsky W, Fisher L, Schikman C, Hinnen D, Parkin C, Jelsovsky Z, et al. Structured
self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled,
noninsulin-treated type 2 diabetes: results from the structured testing program study.
Diabetes Care 2011;34:262e7. https://doi.org/10.2337/dc10-1732.
[80] Fisher L, Polonsky W, Parkin C, Jelsovsky Z, Petersen B, Wagner R. The impact of
structured blood glucose testing on attitudes toward self-management among poorly
controlled, insulin-naı ¨ve patients with type 2 diabetes. Diabetes Research and Clinical
Practice 2012;96:149e55. https://doi.org/10.1016/j.diabres.2011.12.016.
[81] Franciosi M, Lucisano G, Pellegrini F, Cantarello A, Consoli A, Cucco L, et al.
ROSES: role of self-monitoring of blood glucose and intensive education in patients
with Type 2 diabetes not receiving insulin. A pilot randomized clinical trial. Diabetic
Medicine 2011;28:789e96. https://doi.org/10.1111/j.1464-5491.2011.03268.x.
[82] Dura ´n A, Martı ´n P, Runkle I, Pe ´rez N, Abad R, Ferna ´ndez M, et al. Benefits of self-
monitoring blood glucose in the management of new-onset Type 2 diabetes mellitus:
the St Carlos Study, a prospective randomized clinic-based interventional study with
parallel groups. Journal of Diabetes 2010;2:203e11. https://doi.org/10.1111/j.1753-
0407.2010.00081.x.
[83] Bosi E, Scavini M, Ceriello A, Cucinotta D, Tiengo A, Marino R, et al. Intensive struc-
tured self-monitoring of blood glucose and glycemic control in noninsulin-treated type
2 diabetes: the PRISMA randomized trial. Diabetes Care 2013;36:2887e94. https://
doi.org/10.2337/dc13-0092.
[84] Russo G, Scavini M, Acmet E, Bonizzoni E, Bosi E, Giorgino F, et al. The burden of
structured self-monitoring of blood glucose on diabetes-specific quality of life and lo-
cus of control in patients with noninsulin-treated type 2 diabetes: the PRISMA study.
Diabetes Technology and Therapeutics 2016;18:421e8. https://doi.org/10.1089/
dia.2015.0358.
[85] Parsons S, Luzio S, Harvey J, Bain S, Cheung W, Watkins A, et al. Effect of structured
self-monitoring of blood glucose, with and without additional TeleCare support, on
overall glycaemic control in non-insulin treated Type 2 diabetes: the SMBG Study,
a 12-month randomized controlled trial. Diabetic Medicine 2019;36:578e90.
https://doi.org/10.1111/dme.13899.
[86] Farmer A, Perera R, Ward A, Heneghan C, Oke J, Barnett A, et al. Meta-analysis of
individual patient data in randomised trials of self monitoring of blood glucose in peo-
ple with non-insulin treated type 2 diabetes. British Medical Journal 2012;344:e486.
https://doi.org/10.1136/bmj.e486. e486.
[87] Malanda U, Welschen L, Riphagen I, Dekker J, Nijpels G, Bot S. Self-monitoring of
blood glucose in patients with type 2 diabetes mellitus who are not using insulin.
Cochrane Database of Systematic Reviews 2012. https://doi.org/10.1002/
14651858.cd005060.pub3.